Author:
Du Xuexiang,Liu Mingyue,Su Juanjuan,Zhang Peng,Tang Fei,Ye Peiying,Devenport Martin,Wang Xu,Zhang Yan,Liu Yang,Zheng Pan
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference38 articles.
1. Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734–1736 (1996).
2. Kocak, E., et al. Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity. Cancer Res. 66, 7276–7284 (2006).
3. Mokyr, M. B., Kalinichenko, T., Gorelik, L. & Bluestone, J. A. Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice. Cancer Res. 58, 5301–5304 (1998).
4. Hodi, F. S., et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711–723 (2010).
5. Phan, G. Q., et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen-4 blockade in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA 100, 8372–8377 (2003).
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献